|
| Status |
Public on May 22, 2024 |
| Title |
AFC050DXMX2 |
| Sample type |
genomic |
| |
|
| Source name |
Diagnostic Fresh Bone Marrow_MRDposDay15_MRDposEndInduc
|
| Organism |
Homo sapiens |
| Characteristics |
tissue: Diagnostic Fresh Bone Marrow
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
DNA from MACS-sorted blasts were extracted using the Allprep mini kit and the robotic workstation QIAcube (Qiagen, Hilden, Germany) following the manufacturer's protocol
|
| Label |
Cy5, Cy3
|
| Label protocol |
Standard Illumina Protocol
|
| |
|
| Hybridization protocol |
Bisulfite-converted DNA was amplified and hybridized to the Infinium Methylation EPIC Kit chips
|
| Scan protocol |
Illumina’s iScan
|
| Description |
205657370130_R03C01
|
| Data processing |
Low-confidence probes (p-value >0.05) and probes mapped to X and Y chromosomes were excluded from the analysis. Normalization was done using NOOB (background correction method with dye-bias normalization for Illumina Infinium methylation arrays).
|
| |
|
| Submission date |
Apr 05, 2023 |
| Last update date |
May 22, 2024 |
| Contact name |
Jovanny Zabaleta |
| E-mail(s) |
jzabal@lsuhsc.edu
|
| Phone |
504-210 2979
|
| Organization name |
Louisiana State University Health Sciences Center
|
| Department |
Cancer Center/Interdiscipliary Oncology
|
| Lab |
LCRC 909
|
| Street address |
1700 Tulane Ave.
|
| City |
New Orleans |
| State/province |
LA |
| ZIP/Postal code |
70112 |
| Country |
USA |
| |
|
| Platform ID |
GPL21145 |
| Series (2) |
| GSE229052 |
MIR4435-2HG as a novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALL [methylation] |
| GSE229056 |
MIR4435-2HG as a novel predictive biomarker of chemotherapy response and death in pediatric B-cell ALL |
|
